Review Article
Systematic Review of Compound Danshen Dropping Pill: A Chinese Patent Medicine for Acute Myocardial Infarction
Table 6
Analyses of secondary outcomes.
| Outcomes (comparisons) | Treatment (/) | Control (/) | Weight (%) | RR | 95% CI |
| (1) Heart failure | | | | | |
(1.1) CDDP + conventional therapy versus conventional therapy | Xu and Wang 2007 [21] | 3/66 | 12/80 | 32.40 | 0.30 | 0.09, 1.03 | Guo et al. 2010 [20] | 5/76 | 13/60 | 43.40 | 0.30 | 0.11, 0.80 | Li et al. 2011 [19] | 6/252 | 8/248 | 24.10 | 0.74 | 0.26, 2.10 |
| Total (FEM, = 0%) | | | 100.00 | 0.41 |
[0.22, 0.75]
|
| Sensitive analysis | | | | | | Xu and Wang 2007 [21] | 3/66 | 12/80 | 57.30 | 0.30 | 0.09, 1.03 | Guo et al. 2010 [20] | 5/76 | 13/60 | 42.70 | 0.30 | 0.11, 0.80 |
| Total (FEM, = 0%) | | | 100.00 | 0.30 |
[0.14, 0.65]
|
|
(1.2) CDDP + conventional therapy versus placebo + conventional therapy | Li et al. 2010 [36] | 5/42 | 4/21 | 100.00 | 0.63 | 0.19, 2.09 |
(1.3) CDDP + conventional therapy versus propranolol + conventional therapy | Xu and Wang 2007 [21] | 3/66 | 11/72 | 100.00 | 0.26 |
[0.07, 0.99]
| (2) Recurrent angina | | | | | |
(2.1) CDDP + conventional therapy versus conventional therapy | Guo 2010 [20] | 2/76 | 11/60 | 33.40 | 0.14 | 0.03, 0.62 | Li et al. 2011 [19] | 27/252 | 54/248 | 66.60 | 0.49 | 0.32, 0.75 |
| Total (REM, = 61%) | | | 100.00 | 0.33 | [0.10, 1.03] |
|
(2.2) CDDP + conventional therapy versus placebo + conventional therapy | Li et al. 2010 [36] | 12/42 | 11/21 | 100.00 | 0.55 | 0.29, 1.02 | (3) Readmission | | | | | |
CDDP + conventional therapy versus placebo + conventional therapy | Li et al. 2010 [36] | 3/42 | 4/21 | 100.00 | 0.38 | 0.09, 1.52 |
|
|